In vitro activity of tigecycline in combination with rifampin, doripenem or ceftazidime against carbapenem-resistant Klebsiella pneumoniae bloodstream isolates

被引：0
|
作者：
Yongbo Zhang
Peizhen Li
Yuhan Yin
Fuqiang Li
Qinghua Zhang
机构：
[1] An Qiu People’s Hospital,Department of Respiratory Medicine
[2] Liao Cheng Dong Chang Fu People’s Hospital,Department of Clinical Laboratory
[3] Yi Shui People’s Hospital,Department of Clinical Laboratory
来源：
The Journal of Antibiotics | 2017年 / 70卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：193 / 195
页数：2
相关论文
共 50 条
  • [21] Emergence of Ceftazidime/Avibactam and Tigecycline Resistance in Carbapenem-Resistant Klebsiella pneumoniae Due to In-Host Microevolution
    Han, Xinhong
    Shi, Qiucheng
    Mao, Yihan
    Quan, Jingjing
    Zhang, Ping
    Lan, Peng
    Jiang, Yan
    Zhao, Dongdong
    Wu, Xueqing
    Hua, Xiaoting
    Yu, Yunsong
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2021, 11
  • [22] Synergistic antibacterial activity of ceftazidime-avibactam in combination with colistin, gentamicin, amikacin, and fosfomycin against carbapenem-resistant Klebsiella pneumoniae
    Tuzemen, Nazmiye Ulku
    Onal, Ugur
    Merdan, Osman
    Akca, Bekir
    Ener, Beyza
    Ozakin, Cuneyt
    Akalin, Halis
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [23] In vitro and in vivo synergistic effects of tigecycline combined with aminoglycosides on carbapenem-resistant Klebsiella pneumoniae
    Ni, Wentao
    Yang, Deqing
    Guan, Jie
    Xi, Wen
    Zhou, Dexun
    Zhao, Lili
    Cui, Junchang
    Xu, Yu
    Gao, Zhancheng
    Liu, Youning
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2021, 76 (08) : 2097 - 2105
  • [24] In vitro synergistic antimicrobial activity of a combination of meropenem, colistin, tigecycline, rifampin, and ceftolozane/tazobactam against carbapenem-resistant Acinetobacter baumannii
    Yong Guk Ju
    Hak Joon Lee
    Hong Soon Yim
    Min-Goo Lee
    Jang Wook Sohn
    Young Kyung Yoon
    Scientific Reports, 12
  • [25] In vitro synergistic antimicrobial activity of a combination of meropenem, colistin, tigecycline, rifampin, and ceftolozane/tazobactam against carbapenem-resistant Acinetobacter baumannii
    Ju, Yong Guk
    Lee, Hak Joon
    Yim, Hong Soon
    Lee, Min-Goo
    Sohn, Jang Wook
    Yoon, Young Kyung
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [26] The Mobilome of Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates
    Alekseeva, A. E.
    Brusnigina, N. F.
    Gordinskaya, N. A.
    RUSSIAN JOURNAL OF GENETICS, 2020, 56 (03) : 280 - 288
  • [27] The Mobilome of Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates
    A. E. Alekseeva
    N. F. Brusnigina
    N. A. Gordinskaya
    Russian Journal of Genetics, 2020, 56 : 280 - 288
  • [28] Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections
    Neuner, Elizabeth A.
    Yeh, Jun-Yen
    Hall, Gerri S.
    Sekeres, Jennifer
    Endimiani, Andrea
    Bonomo, Robert A.
    Shrestha, Nabin K.
    Fraser, Thomas G.
    van Duin, David
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2011, 69 (04) : 357 - 362
  • [29] Antibacterial Activity and Optimal Treatment of Ceftazidime-Avibactam and Aztreonam-Avibactam Against Bloodstream Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae
    Yu, Wei
    Chen, Yunbo
    Shen, Ping
    Ji, Jinru
    Ying, Chaoqun
    Liu, Zhiying
    Xiong, Luying
    Qiu, Yunqing
    Xiao, Yonghong
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [30] CusS-cusR mediate carbapenem-resistant Klebsiella pneumoniae resistant to tigecycline
    Chen, Dongjie
    Li, Hongru
    Xiao, Liying
    Li, Xiaoqin
    Hu, Xinlan
    He, Huaqiang
    Chen, Yusheng
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
12345